SEC 13F Intelligence

Hood River Capital Management LLC / IOVA

Hood River Capital Management LLC’s Iovance Biotherapeutics Inc Position

Does Hood River Capital Management LLC own Iovance Biotherapeutics Inc (IOVA)? Not currently — the last reported position was 9.22M shares worth $31M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$31M
Q1 2025
Shares
9.22M
% of Portfolio
+0.52%
Quarters Held
12
position exited

Position History IOVA

Reported value by quarter
Q2 ’20: $15MQ2 ’20Q3 ’20: $16MQ4 ’20: $23MQ4 ’20Q1 ’21: $15MQ2 ’23: $14MQ2 ’23Q3 ’23: $9MQ4 ’23: $16MQ4 ’23Q1 ’24: $39MQ2 ’24: $22MQ2 ’24Q3 ’24: $76MQ4 ’24: $67MQ4 ’24Q1 ’25: $31Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20259.22M$31M+0.52%
Q4 20248.99M$67M+0.98%
Q3 20248.14M$76M+1.23%
Q2 20242.73M$22M+0.45%
Q1 20242.62M$39M+0.87%
Q4 20232.00M$16M+0.45%
Q3 20231.99M$9M+0.29%
Q2 20231.98M$14M+0.41%
Q1 2021460.7K$15M+0.47%
Q4 2020505.4K$23M+0.78%
Q3 2020496.9K$16M+0.71%
Q2 2020547.3K$15M+0.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hood River Capital Management LLC’s full portfolio or all institutional holders of IOVA.